Animosity
发表于 2025-3-21 19:02:59
书目名称Antibody Therapy影响因子(影响力)<br> http://figure.impactfactor.cn/if/?ISSN=BK0158479<br><br> <br><br>书目名称Antibody Therapy影响因子(影响力)学科排名<br> http://figure.impactfactor.cn/ifr/?ISSN=BK0158479<br><br> <br><br>书目名称Antibody Therapy网络公开度<br> http://figure.impactfactor.cn/at/?ISSN=BK0158479<br><br> <br><br>书目名称Antibody Therapy网络公开度学科排名<br> http://figure.impactfactor.cn/atr/?ISSN=BK0158479<br><br> <br><br>书目名称Antibody Therapy被引频次<br> http://figure.impactfactor.cn/tc/?ISSN=BK0158479<br><br> <br><br>书目名称Antibody Therapy被引频次学科排名<br> http://figure.impactfactor.cn/tcr/?ISSN=BK0158479<br><br> <br><br>书目名称Antibody Therapy年度引用<br> http://figure.impactfactor.cn/ii/?ISSN=BK0158479<br><br> <br><br>书目名称Antibody Therapy年度引用学科排名<br> http://figure.impactfactor.cn/iir/?ISSN=BK0158479<br><br> <br><br>书目名称Antibody Therapy读者反馈<br> http://figure.impactfactor.cn/5y/?ISSN=BK0158479<br><br> <br><br>书目名称Antibody Therapy读者反馈学科排名<br> http://figure.impactfactor.cn/5yr/?ISSN=BK0158479<br><br> <br><br>
条街道往前推
发表于 2025-3-22 00:11:24
From Immune Substitution to Immuno-modulationestones in the history of human immunoglobulins since the initial observation by Ogden C. Bruton who described replacement therapy in a single boy with agammaglobulinemia. Since then, the preparations used for treatment have been markedly improved with respect to tolerability, clinical efficacy, and
搬运工
发表于 2025-3-22 02:00:23
http://reply.papertrans.cn/16/1585/158479/158479_3.png
知识
发表于 2025-3-22 07:33:00
http://reply.papertrans.cn/16/1585/158479/158479_4.png
吼叫
发表于 2025-3-22 11:01:26
Immunomodulatory Drugs and Monoclonal Antibodies development of most such disorders, but an external trigger may be required for the eventual development of the autoimmune disease. The development of pharmacologic agents to treat such disorders by inducing self-tolerance has progressed over the last 60 years. Historically termed immunosuppressive
Aerate
发表于 2025-3-22 15:11:03
http://reply.papertrans.cn/16/1585/158479/158479_6.png
混合,搀杂
发表于 2025-3-22 20:52:07
http://reply.papertrans.cn/16/1585/158479/158479_7.png
Expiration
发表于 2025-3-22 22:27:38
http://reply.papertrans.cn/16/1585/158479/158479_8.png
恶臭
发表于 2025-3-23 02:20:03
Essentials of the Production of Safe and Efficacious State-of-the-Art Polyclonal IgG Concentratesal use were threats for recipients (see Chap. . for additional information). “Standard IgG” preparations were the first available for clinical use. They were produced by the cold-ethanol fractionation methods and did not make an exception. Noninfectious severe AEs occurred while infectious AEs were
不溶解
发表于 2025-3-23 06:17:43
http://reply.papertrans.cn/16/1585/158479/158479_10.png